Client Image

    Ferring Pharmaceuticals

    Visit Corporate Website

    Ferring Pharmaceuticals

    Ferring is conducting a trial to investigate if men diagnosed with idiopathic infertility and treated with rFSH (a recombinant follicle stimulating hormonal treatment) once daily for 6 months have an increased chance of their partner achieving a natural pregnancy. The study aims to be able to boost spontaneous pregnancy rates and is taking place at approximately 25 sites across 7 countries in Europe and North America.

    For more information on the trial, please contact: dk0-disclosure@ferring.com